$10.53 0.16 (+1.54%)
11/24/2009 4:00 PM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Featured Broker Partners